NGN Capital is a New York, US-based venture capital firm that invests across all venture capital development stages, with a particular emphasis on expansion/late stage investments. The firm channels its investments across a broad cross-section of healthcare and biotechnology segments including drug products, medical devices and other healthcare segments such as services, investing predominantly within the US and in Europe.
Venture Capital
369 LEXINGTON AVENUE
26TH FLOOR
NEW YORK, NY, 10017
United States
3 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.